Clinical trial
Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients…
NCT00482638 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00482638 |
|---|---|
| Title | Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED) |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | MK0493 |
| Start date | May 12, 2004 |
| Primary completion | Oct 29, 2004 |
| Completion | Oct 29, 2004 |
| First posted | Jun 5, 2007 |
| Last update posted | Nov 14, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: